The role of AMPK in controlling metabolism and mitochondrial biogenesis during exercise

Experimental Physiology

Volumn 99, Issue 12, 2014, Pages 1581-1585

  Marcinko, Katarina ^a   Steinberg, Gregory R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; ADENYLATE KINASE;

ARTICLE; BIOGENESIS; ENDURANCE TRAINING; ENZYME PHOSPHORYLATION; EXERCISE; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLISM; MITOCHONDRION; MUSCLE CONTRACTION; NONHUMAN; REGULATORY MECHANISM; SKELETAL MUSCLE; ANIMAL; ANIMAL EXPERIMENT; MITOCHONDRIAL DYNAMICS; MUSCLE MITOCHONDRION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ADENYLATE KINASE; ANIMALS; BIOLOGICAL TRANSPORT; EXERCISE; GLUCOSE; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL TURNOVER; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; SIGNAL TRANSDUCTION;

EID: 84925004916     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.082255     Document Type: Article

References (28)

1. Abbott MJ, Edelman AM & Turcotte LP (2009). CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am J Physiol Regul Integr Comp Physiol 297, R1724-R1732.
2. Adhihetty PJ, Uguccioni G, Leick L, Hidalgo J, Pilegaard H & Hood DA (2009). The role of PGC-1α on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol 297, C217-C225.
3. Barnes BR, Marklund S, Steiler TL, Walter M, Hjälm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR & Andersson L (2004). The 5′-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279, 38441-38447.
4. Bujak AL, Blümer RM, Marcinko K, Fullerton MD, Kemp BE & Steinberg GR (2014). Reduced skeletal muscle AMPK and mitochondrial markers do not promote age-induced insulin resistance. J Appl Physiol 117, 171-179.
5. Dzamko N, Schertzer JD, Ryall JG, Steel R, Macaulay SL, Wee S, Chen ZP, Michell BJ, Oakhill JS, Watt MJ, Jørgensen SB, Lynch GS, Kemp BE & Steinberg GR (2008). AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol 586, 5819-5831.
6. Dzamko N, van Denderen BJW, Hevener AL, Jørgensen SB, Honeyman J, Galic S, Chen ZP, Watt MJ, Campbell DJ, Steinberg GR & Kemp BE (2010). AMPK β1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem 285, 115-122.
7. Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, Seifert MM & Goodyear LJ (2005). AMP-activated protein kinase α2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 280, 39033-39041.
8. Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, O'Neill HM, Ford RJ, Palanivel R, O'Brien M, Hardie DG, Macaulay SL, Schertzer JD, Dyck JRB, van Denderen BJ, Kemp BE & Steinberg GR (2013). Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med 19, 1649-1654.
9. Galic S, Fullerton MD, Schertzer JD, Sikkema S, Marcinko K, Walkley CR, Izon D, Honeyman J, Chen ZP, van Denderen BJ, Kemp BE & Steinberg GR (2011). Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121, 4903-4915.
10. Garcia-Roves PM, Osler ME, Holmström MH & Zierath JR (2008). Gain-of-function R225Q mutation in AMP-activated protein kinase γ3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem 283, 35724-35734.
11. Jeppesen J, Albers PH, Rose AJ, Birk JB, Schjerlong P, Dzamko N, Steinberg GR & Kiens B (2011). Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent. J Lipid Res 52, 699-711.
12. Jeppesen J, Maarbjerg SJ, Jordy AB, Fritzen AM, Pehmøller C, Sylow L, Serup AK, Jessen N, Thorsen K, Prats C, Qvortrup K, Dyck JR, Hunter RW, Sakamoto K, Thomson DM, Schjerling P, Wojtaszewski JF, Richter EA & Kiens B (2013). LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes 62, 1490-1499.
13. Jørgensen SB, Treebak JT, Viollet B, Schjerling P, Vaulont S, Wojtaszewski JFP & Richter EA (2007). Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 292, E331-339.
14. 1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279, 1070-1079.
15. Lantier L, Fentz J, Mounier R, Leclerc J, Treebak JT, Pehmøller C, Sanz N, Sakakibara I, Saint-Amand E, Rimbaud S, Maire P, Marette A, Ventura-Clapier R, Ferry A, Wojtaszewski JFP, Foretz M & Viollet B (2014). AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. FASEB J 28, 3211-3224.
16. Leick L, Hellsten Y, Fentz J, Lyngby SS, Wojtaszewski JF, Hidalgo J & Pilegaard H (2009). PGC-1alpha mediates exercise-induced skeletal muscle VEGF expression in mice. Am J Physiol Endocrinol Metab 297, E92-E103.
17. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E & Spriet LL (1998). Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am J Physiol Endocrinol Metab 274, E1080-E1085.
18. O'Neill HM, Holloway GP & Steinberg GR (2012). AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity. Mol Cell Endocrinol 366, 135-151.
19. O'Neill HM, Lally JS, Galic S, Thomas M, Azizi PD, Fullerton MD, Smith BK, Pulinilkunnil T, Chen Z, Samaan MC, Jorgensen SB, Dyck JR, Holloway GP, Hawke TJ, van Denderen BJ, Kemp BE & Steinberg GR (2014). AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 57, 1693-1702.
20. O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jørgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, Kemp BE, Richter EA & Steinberg GR (2011). AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A 108, 16092-16097.
21. Philp A, Chen A, Lan D, Meyer GA, Murphy AN, Knapp AE, Olfert IM, McCurdy CE, Marcotte GR, Hogan MC, Baar K & Schenk S (2011). Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial biogenesis or peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) deacetylation following endurance exercise. J Biol Chem 286, 30561-30570.
22. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JFP, Richter EA & Kiens B (2005). Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinol Metab 288, E133-E142.
23. 50 for CPT-I: implications for predicting in vivo fatty acid oxidation rates. Biochem J 448, 13-20.
24. Steinberg GR & Jørgensen SB (2007). The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 7, 519-526.
25. Steinberg GR, O'Neill HM, Dzamko NL, Galic S, Naim T, Koopman R, Jørgensen SB, Honeyman J, Hewitt K, Chen ZP, Schertzer JD, Scott JW, Koentgen F, Lynch GS, Watt MJ, van Denderen BJW, Campbell DJ & Kemp BE (2010). Whole body deletion of AMP-activated protein kinase β2 reduces muscle AMPK activity and exercise capacity. J Biol Chem 285, 37198-37209.
26. Tanner CB, Madsen SR, Hallowell DM, Goring DM, Moore TM, Hardman SE, Heninger MR, Atwood DR & Thomson DM (2013). Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1. Am J Physiol Endocrinol Metab 305, E1018-1029.
27. Thomas MM, Wang DC, D'Souza DM, Krause MP, Layne AS, Criswell DS, O'Neill HM, Connor MK, Anderson JE, Kemp BE, Steinberg GR & Hawke TJ (2014). Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles. FASEB J 28, 2098-2107.
28. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA & Ruderman NB (1997). Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272, 13255-13261.